NEW YORK, Nov. 28 – Biotechnology company Pluvita has signed a three-year, non-exclusive deal for access to AxCell Bioscience’s ProChart database, which contains information on signal transduction pathways in the human proteome, AxCell said Wednesday. Financial terms of the deal were not disclosed.

The database includes the map of the WW protein domain family, a complete human domain family involved in signal transduction. ProChart also includes protein pathway information from several other domain families, such as PDZ, SH2 and SH3.